Status:
COMPLETED
COVID-19 Serologies Among Healthcare Workers at CHSD (SERO2)
Lead Sponsor:
Centre Hospitalier de Saint-Denis
Conditions:
COVID-19
COVID-19 Serological Testing
Eligibility:
All Genders
Brief Summary
This study looks at how many healthcare workers at CHSD hospital developed antibodies against COVID-19 after the second and third waves of the pandemic and after receiving a vaccine. It aims to better...
Eligibility Criteria
Inclusion
- \- Volunteers from the hospital staff who have signed a new informed consent form
Exclusion
- Refusal to participate (no signed consent form)
- Staff unavailable during the blood sampling period
- Participation only in the first seroprevalence survey without consent for the second
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
447 Patients enrolled
Trial Details
Trial ID
NCT06989307
Start Date
March 1 2021
End Date
June 1 2021
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
France
Saint-Denis, France, France